Literature DB >> 18061791

New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.

T Rinda Soong1, Lili A Barouch, Hunter C Champion, Frederick M Wigley, Marc K Halushka.   

Abstract

Hydroxychloroquine- or chloroquine -induced cardiomyopathy is a rare but potentially fatal condition. Hydroxychloroquine and chloroquine are often used for long-term treatment of rheumatic diseases and for malaria prophylaxis. Hydroxychloroquine- and chloroquine-induced cardiomyopathy have well-described microscopic features, with the classic electron microscopic findings of myelin figures (myeloid bodies). We report on 2 new cases with novel findings. The first case, in a patient with systemic lupus erythematosus, was found to have megamitochondria in addition to myelin figures seen by electron microscopy. The second report describes the first case of hydroxychloroquine cardiomyopathy described in a patient with scleroderma. These novel findings will add to the present knowledge of hydroxychloroquine-induced cardiomyopathy in its pathology and its implication for treatment of rheumatic diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061791     DOI: 10.1016/j.humpath.2007.06.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis.

Authors:  Amr Abdin; Janine Pöss; Reinhard Kandolf; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-12-21       Impact factor: 5.460

3.  Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.

Authors:  Dan L Li; Zhao V Wang; Guanqiao Ding; Wei Tan; Xiang Luo; Alfredo Criollo; Min Xie; Nan Jiang; Herman May; Viktoriia Kyrychenko; Jay W Schneider; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2016-03-16       Impact factor: 29.690

4.  No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.

Authors:  Deborah Friedman; Leif Lovig; Marc Halushka; Robert M Clancy; Peter M Izmirly; Jill P Buyon
Journal:  Clin Exp Rheumatol       Date:  2017-06-06       Impact factor: 4.473

5.  Acute left ventricular failure in a patient with hydroxychloroquine-induced cardiomyopathy.

Authors:  M Hartmann; I L Meek; G K van Houwelingen; H P C M Lambregts; G J Toes; A C van der Wal; C von Birgelen
Journal:  Neth Heart J       Date:  2011-11       Impact factor: 2.380

Review 6.  Cardiomyocyte autophagy and cancer chemotherapy.

Authors:  Dan L Li; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2013-11-14       Impact factor: 5.000

7.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

Review 8.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

9.  Hydroxychloroquine-induced cardiomyopathy and heart failure in twins.

Authors:  Hang Zhao; Joyce Wald; Michael Palmer; Yuchi Han
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 10.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.